Smoke, smoke, smoke that cigarette

Perspectives in Psychiatric Care

Volumn 42, Issue 4, 2006, Pages 256-261

  Keltner, Norman L ^a   Grant, Joan S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR;

ATTITUDE TO HEALTH; CASE REPORT; COGNITION; DECISION MAKING; DOWN REGULATION; HEALTH BEHAVIOR; HUMAN; IRRITABILITY; LIFESTYLE; MALE; METHODOLOGY; MIDDLE AGED; MOTIVATION; NURSE ATTITUDE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHIATRIC NURSING; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; REVIEW; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION;

ATTITUDE TO HEALTH; CHOICE BEHAVIOR; COGNITION; DOWN-REGULATION; HEALTH BEHAVIOR; HUMANS; IRRITABLE MOOD; LIFE STYLE; MALE; MIDDLE AGED; MOTIVATION; NURSE'S ROLE; PSYCHIATRIC NURSING; RECEPTORS, DOPAMINE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING; SMOKING CESSATION;

EID: 33750985350     PISSN: 00315990     EISSN: 17446163     Source Type: Journal    
DOI: 10.1111/j.1744-6163.2006.00085.x     Document Type: Review

References (38)

1. Adler, L. E., Olincy, A., Waldo, M., Harris, J. G., Griffith, J., Stevens, K., et al. (1998). Schizophrenia, sensory gating, and nicotinic receptors. Schizophrenia Bulletin, 24, 189-202.
2. Baxter, D. N. (1996). The mortality experience of individuals on the Salford psychiatric case register. British Journal of Psychiatry, 168, 772-779.
3. Breslau, N., Novak, S. P., & Kessler, R. C. (2004). Psychiatric disorders and stages of smoking. Biological Psychiatry, 55(1), 69-74.
4. Bradshaw, T., Lovell, K., & Harris, N. (2005). Healthy living interventions and schizophrenia: A systematic review. Journal of Advanced Nursing, 49(6), 634-654.
5. Chou, K. R., Chen, R., Lee, J. F., Ku, C. H., & Lu, R. B. (2004). The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. International Journal of Nursing Studies, 41(3), 321-330.
6. Cohn, T., Prud'homme, D., Streiner, D., Kameh, H., & Remington, G. (2004). Characterizing coronary heart disease risk in people with schizophrenia: High prevalence of the metabolic syndrome. Canadian Journal of Psychiatry, 49, 753-760.
7. Dalack, G. W., Healy, D. J., & Meador-Woodruff, J. H. (1998). Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings. American Journal of Psychiatry, 155, 1490.
8. Decina, P., Caracci, G., Sandik, R., Berman, W., Mukherjee, S., & Scapicchio, P. (1990). Cigarette smoking and neuroleptic-induced parkinsonism. Biological Psychiatry, 28(6), 502-508.
9. de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76(2-3), 135-157.
10. Els, C. (2004). What is the role of pharmacotherapy in tobacco cessation in patients with schizophrenia? Journal of Psychiatry & Neuroscience, 29(3), 240.
11. Esterberg, M. L., & Compton, M. T. (2005). Smoking behavior in persons with schizophrenia spectrum disorder: A qualitative investigation of the transtheoretical model. Social Science & Medicine, 61, 293.
12. Evins, A. E., Cather, C., Deckersbach, T., Freudenreich, O., Culhane, M. A., Olm-Shipman, C. M., et al. (2005). A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. Journal of Clinical Psychopharmacology, 25(3), 218-225.
13. Evins, A. E., Cather, C., Rigotti, N. A., Freudenreich, O., Henderson, D. C., Olm-Shipman, C. M., et al. (2004). Two-year follow-up of a smoking cessation trial in patients with schizophrenia: Increased rates of smoking cessation and reduction. Journal of Clinical Psychiatry, 65(3), 307-311; quiz 452-453.
14. Evins, A. E., Deckersbach, T., Cather, C., Freudenreich, O., Culhane, M. A., Henderson, D. C., et al. (2005). Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. Journal of Clinical Psychiatry, 66(9), 1184-1190.
15. Fiore, M. C., Bailey, W. C., & Cohen, S. J. (2000). Treating tobacco use and dependence. Clinical practice guideline. Rockville MD: US Department of Health and Human Services. Public Health Service.
16. Fiore, M. C. (2000). US Public Health Service clinical practice guideline: Treating tobacco use and dependence. Respiratory Care, 45(10), 1200-1262.
17. Friedman, J. I., Stewart, D. G., & Gorman, J. M. (2004). Potential noradrenergic targets for cognitive enhancement in schizophrenia. CNS Spectrums, 9(5), 350-355.
18. George, T. P., Ziedonis, D. M., Feingold, A., Pepper, W. T., Satterburg, C. A., & Winkel, J. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157(11), 1835-1842.
19. Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., et al. (2005). A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research, 80(1), 45-53.
20. Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005). Schizophrenia and increased risks of cardiovascular disease. American Heart Journal, 150(6), 1115-1121.
21. Keltner, N. L. (2006). Metabolic syndrome: Schizophrenia and atypical antipsychotics. Perspectives in Psychiatric Care, 42(3), 195-198.
22. Kuehn, B. M. (2006). Link between smoking and mental illness may lead to treatments. JAMA, 295, 483-484.
23. McEvoy, J. P. (2005). Cigarette smoking and schizophrenia. Managing health risks in psychiatric patients: Practical clinical interventions (Supplement to Clinical Psychiatry News). Philadelphia: Elsevier.
24. Myers, C. S., Robles, O., Kakoyannis, A. N., Sherr, J. D., Avila, M. T., Blaxton, T. A., et al. (2004). Nicotine improves delayed recognition in schizophrenic patients. Psychopharmacology, 174, 334-340.
25. National Cancer Institute. (2006). Cigarette smoking and cancer: Questions and answers. Retrieved May 17, 2006, from www.cancer.gov/cancertopics/ factsheet/Tobacco/cancer
26. Osby, U., Correia, N., Brandt, L., Ekbom, A., & Sparen P. (2000). Mortality and causes of death in schizophrenia in Stockholm County, Sweden. Schizophrenia Research, 45(1-2), 21-28.
27. Patkar, A. A., Gopalakrishnan, R., Lundy, A., Leone, F. T., Certa, K. M., & Weinstein, S. P. (2002). Relationship between tobacco smoking and positive and negative symptoms in schizophrenia. Journal of Nervous and Mental Disease, 190, 604-610.
28. Postma, P., Gray, J. A., Sharma, T., Geyer, M., Mehrotra, R., Das, M., et al. (2006). A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. Psychopharmacology (Berl)., 184(3-4), 589-599. Epub 2006 Feb 2.
29. Sacco, K. A., Bannon, K. L., & George, T. P. (2004). Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. Journal of Psychopharmacology, 18(4), 457-474.
30. Salokangas, R. K., Saarijarvi, S., Taiminen, T., Lehto, H., Niemi, H., Ahola, V., et al. (1997). Effect of smoking on neuroleptics in schizophrenia. Schizophrenia Research, 23(1), 55-60.
31. Sherman, C. (2005). Vicious circle of comorbidity links medical, mental illness. Clinical Psychiatry News, 33(10), 66.
32. Stahl, S. M. (2000). Essential psychopharmacology. Cambridge, UK: Cambridge University Press.
33. Steinberg, M. L., Williams, J. M., & Ziedonis, D. M. (2004). Financial implications of cigarette smoking among individuals with schizophrenia. Tobacco Control, 13, 206-208.
34. Swan, G. E., Valdes, A., Ring, H. Z., Khroyan, T. V., Jack, L. M., Ton, C. C., et al. (2005). Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR. Pharmacogenomics Journal, 5, 21-29.
35. Tidey, J. W., Rohsenow, D. J., Kaplan, G. B., & Swift, R. M. (2005). Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug & Alcohol Dependence, 80(2), 259-265.
36. Van Dongen, C. J. (1999). Smoking and persistent mental illness: An exploratory study. Journal of Psychosocial Nursing, 37(11), 26-34.
37. Wilson, P. W., D'Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998). Prediction of coronary heart disease using risk factor categories. Circulation, 97, 1837-1847.
38. Ziedonis, D. M., Wyatt, S. A., & George, T. P. (1998). Current issues in nicotine dependence and treatment. In E. F. McCance-Katz & T. Kosten (Eds.), New Treatments for Chemical Addictions. Washington, DC: American Psychological Association.